{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:23:55Z","timestamp":1773865435062,"version":"3.50.1"},"reference-count":84,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Antisynthetase syndrome (ASyS) is an acquired myopathy characterized by the presence of myositis-specific autoantibodies directed against tRNA-synthetases. ASyS is potentially life threatening due to lung involvement and treatment remains a challenge to date. With symptoms not limited to muscles but also involving lung, skin and joints, ASyS appears specific and has a particular pathogenesis, different from the other inflammatory myopathies. This review is intended to discuss the current understanding of ASyS pathogenesis, pointing its current knowledge and also the crucial prospects that may lead to critical improvement of ASyS care.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Regarding ASyS pathogenesis, initiation of the disease seems to arise in a multifactorial context, with first lesions occurring within the lungs. This may lead to aberrant self-antigen exposure and tolerance breakdown. The consequences are abnormal activation of both innate and adaptive immunity, resulting in the patients with favourable genetic background to autoimmune-mediated organ lesions. Immune and nonimmune roles of the antigen, as well as antigen presentation leading to specific T-cell and B-cell activation and to the production of specific autoantibodies belong to the disease process.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>This work aims to detail ASyS pathogenesis understanding, from initiation to the disease propagation and target tissue lesions, in order to considering future treatment directions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000555","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T22:05:34Z","timestamp":1537999534000},"page":"664-673","source":"Crossref","is-referenced-by-count":59,"title":["Antisynthetase syndrome pathogenesis: knowledge and uncertainties"],"prefix":"10.1097","volume":"30","author":[{"given":"Laure","family":"Gallay","sequence":"first","affiliation":[{"name":"D\u00e9partement de M\u00e9decine Interne et Immunologie Clinique, Centre Hospitalo-Universitaire Edouard Herriot, Hospices Civils de Lyon"},{"name":"INMG, CNRS UMR 5310 - INSERM U1217, University Claude Bernard, Lyon 1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Gayed","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9s, Universit\u00e9 Pierre et Marie Curie Universit\u00e9 Paris 06, INSERM U1135, CNRS ERL8255, Centre d\u2019Immunologie et des Maladies Infectieuses"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baptiste","family":"Hervier","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9s, Universit\u00e9 Pierre et Marie Curie Universit\u00e9 Paris 06, INSERM U1135, CNRS ERL8255, Centre d\u2019Immunologie et des Maladies Infectieuses"},{"name":"D\u00e9partement de M\u00e9decine Interne et Immunologie Clinique, Centre National de R\u00e9f\u00e9rence des Maladies Musculaires, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230901","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"R2-20230901","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/joim.12451","article-title":"Myositis-specific autoantibodies: an important tool to support diagnosis of myositis","volume":"280","author":"Betteridge","year":"2016","journal-title":"J Intern Med"},{"key":"R3-20230901","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11926-013-0349-8","article-title":"Clinical heterogeneity and outcomes of antisynthetase syndrome","volume":"15","author":"Hervier","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"R4-20230901","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/art.1780260505","article-title":"The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis","volume":"26","author":"Yoshida","year":"1983","journal-title":"Arthritis Rheum"},{"key":"R5-20230901","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1093\/brain\/awv192","article-title":"Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis","volume":"138","author":"Mescam-Mancini","year":"2015","journal-title":"Brain J Neurol"},{"key":"R6-20230901","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s40478-014-0154-2","article-title":"Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy","volume":"2","author":"Aouizerate","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"R7-20230901","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S1074-7613(00)00080-7","article-title":"Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion","volume":"13","author":"Bouneaud","year":"2000","journal-title":"Immunity"},{"key":"R8-20230901","first-page":"154","article-title":"Natural autoantibodies: from \u2018horror autotoxicus\u2019 to \u2018gnothi seauton.\u2019","volume":"12","author":"Avrameas","year":"1991","journal-title":"Immunol Today"},{"key":"R9-20230901","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/ni.3731","article-title":"The multiple pathways to autoimmunity","volume":"18","author":"Theofilopoulos","year":"2017","journal-title":"Nat Immunol"},{"key":"R10-20230901","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrg.2015.33","article-title":"Autoimmune diseases: connecting risk alleles with molecular traits of the immune system","volume":"17","author":"Gutierrez-Arcelus","year":"2016","journal-title":"Nat Rev Genet"},{"key":"R11-20230901","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1172\/JCI78082","article-title":"Sexual dimorphism in autoimmunity","volume":"125","author":"Rubtsova","year":"2015","journal-title":"J Clin Invest"},{"key":"R12-20230901","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.immuni.2015.09.007","article-title":"Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine","volume":"43","author":"Haghikia","year":"2015","journal-title":"Immunity"},{"key":"R13-20230901","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.chest.2015.10.067","article-title":"Lung function trajectories in world trade center-exposed New York City firefighters over 13 years the roles of smoking and smoking cessation","volume":"149","author":"Aldrich","year":"2016","journal-title":"Chest"},{"key":"R14-20230901","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mayocp.2015.09.019","article-title":"Post-September 11, 2001, incidence of systemic autoimmune diseases in World Trade Center-exposed firefighters and emergency medical service workers","volume":"91","author":"Webber","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"R15-20230901","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.autrev.2016.01.001","article-title":"Smoke and autoimmunity: the fire behind the disease","volume":"15","author":"Perricone","year":"2016","journal-title":"Autoimmun Rev"},{"key":"R16-20230901","doi-asserted-by":"crossref","first-page":"J258","DOI":"10.1016\/j.jaut.2009.12.003","article-title":"Effects of tobacco smoke on immunity, inflammation and autoimmunity","volume":"34","author":"Arnson","year":"2010","journal-title":"J Autoimmun"},{"key":"R17-20230901","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2015.02.011","article-title":"Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection","volume":"42","author":"Kearley","year":"2015","journal-title":"Immunity"},{"key":"R18-20230901","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/art.39059","article-title":"Nested case-control study of selected systemic autoimmune diseases in World Trade Center rescue\/recovery workers","volume":"67","author":"Webber","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R19-20230901","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1002\/art.39263","article-title":"Reply: to PMID 25779102","volume":"67","author":"Webber","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R20-20230901","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/thx.2006.069237","article-title":"Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset","volume":"63","author":"Tillie-Leblond","year":"2008","journal-title":"Thorax"},{"key":"R21-20230901","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/annrheumdis-2011-200182","article-title":"Interaction of HLA-DRB1\u221703 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study","volume":"71","author":"Chinoy","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R22-20230901","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1136\/annrheumdis-2017-211174","article-title":"Infections and respiratory tract disease as risk factors for idiopathic inflammatory myopathies: a population-based case-control study","volume":"76","author":"Svensson","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R23-20230901","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3389\/fphar.2013.00173","article-title":"The epithelium in idiopathic pulmonary fibrosis: breaking the barrier","volume":"4","author":"Camelo","year":"2014","journal-title":"Front Pharmacol"},{"key":"R24-20230901","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1513\/pats.200710-160DR","article-title":"What differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosis","volume":"5","author":"Strieter","year":"2008","journal-title":"Proc Am Thorac Soc"},{"key":"R25-20230901","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12890-018-0609-5","article-title":"Elevated \u03b1-defensin levels in plasma and bronchoalveolar lavage fluid from patients with myositis-associated interstitial lung disease","volume":"18","author":"Sakamoto","year":"2018","journal-title":"BMC Pulm Med"},{"key":"R26-20230901","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/cei.12319","article-title":"Enhanced formation and impaired degradation of neutrophil extracellular traps in dermatomyositis and polymyositis: a potential contributor to interstitial lung disease complications","volume":"177","author":"Zhang","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"R27-20230901","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1089\/hum.1997.8.12-1469","article-title":"Myositis induced by naked DNA immunization with the gene for histidyl-tRNA synthetase","volume":"8","author":"Blechynden","year":"1997","journal-title":"Hum Gene Ther"},{"key":"R28-20230901","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaut.2007.07.005","article-title":"Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation","volume":"29","author":"Katsumata","year":"2007","journal-title":"J Autoimmun"},{"key":"R29-20230901","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/art.30113","article-title":"Role of innate immunity in a murine model of histidyl-transfer RNA synthetase (Jo-1)-mediated myositis","volume":"63","author":"Soejima","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R30-20230901","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.4049\/jimmunol.1203070","article-title":"Functional redundancy of MyD88-dependent signaling pathways in a murine model of histidyl-transfer RNA synthetase-induced myositis","volume":"191","author":"Fernandez","year":"2013","journal-title":"J Immunol"},{"key":"R31-20230901","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/art.40503","article-title":"Exacerbation of murine experimental autoimmune myositis by toll-like receptor 7\/8","volume":"70","author":"Sciorati","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R32-20230901","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/art.38985","article-title":"Required role of apoptotic myogenic precursors and toll-like receptor stimulation for the establishment of autoimmune myositis in experimental murine models","volume":"67","author":"Sciorati","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R33-20230901","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1084\/jem.190.6.815","article-title":"Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity","volume":"190","author":"Casciola-Rosen","year":"1999","journal-title":"J Exp Med"},{"key":"R34-20230901","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1002\/art.22790","article-title":"Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis","volume":"56","author":"Levine","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R35-20230901","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.4049\/jimmunol.1501902","article-title":"Involvement of NK cells and NKp30 pathway in antisynthetase syndrome","volume":"197","author":"Hervier","year":"2016","journal-title":"J Immunol"},{"key":"R36-20230901","doi-asserted-by":"crossref","first-page":"e58556","DOI":"10.1371\/journal.pone.0058556","article-title":"Differential activation of killer cells in the circulation and the lung: a study of current smoking status and chronic obstructive pulmonary disease (COPD)","volume":"8","author":"Wang","year":"2013","journal-title":"PloS One"},{"key":"R37-20230901","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.20090681","article-title":"The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans","volume":"206","author":"Brandt","year":"2009","journal-title":"J Exp Med"},{"key":"R38-20230901","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood-2013-01-476606","article-title":"Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell antitumor activity","volume":"121","author":"Reiners","year":"2013","journal-title":"Blood"},{"key":"R39-20230901","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1172\/JCI114461","article-title":"Origin and regulation of a disease-specific autoantibody response. Antigenic epitopes, spectrotype stability, and isotype restriction of anti-Jo-1 autoantibodies","volume":"85","author":"Miller","year":"1990","journal-title":"J Clin Invest"},{"key":"R40-20230901","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.4049\/jimmunol.138.9.2874","article-title":"Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity","volume":"138","author":"Targoff","year":"1987","journal-title":"J Immunol"},{"key":"R41-20230901","doi-asserted-by":"crossref","first-page":"E640","DOI":"10.1073\/pnas.1200194109","article-title":"Secreted human glycyl-tRNA synthetase implicated in defense against ERK-activated tumorigenesis","volume":"109","author":"Park","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R42-20230901","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1515\/BC.1999.079","article-title":"Histidyl-tRNA synthetase","volume":"380","author":"Freist","year":"1999","journal-title":"Biol Chem"},{"key":"R43-20230901","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00125-013-2839-7","article-title":"Histidine supplementation improves insulin resistance through suppressed inflammation in obese women with the metabolic syndrome: a randomised controlled trial","volume":"56","author":"Feng","year":"2013","journal-title":"Diabetologia"},{"key":"R45-20230901","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ng1727","article-title":"Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy","volume":"38","author":"Jordanova","year":"2006","journal-title":"Nat Genet"},{"key":"R46-20230901","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ajhg.2009.12.005","article-title":"A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease","volume":"86","author":"Latour","year":"2010","journal-title":"Am J Hum Genet"},{"key":"R47-20230901","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3109\/13547501003777823","article-title":"Autoantibodies against aminoacyl-tRNA synthetase: novel diagnostic marker for type 1 diabetes mellitus","volume":"15","author":"Park","year":"2010","journal-title":"Biomark"},{"key":"R48-20230901","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nchembio.1158","article-title":"Essential nontranslational functions of tRNA synthetases","volume":"9","author":"Guo","year":"2013","journal-title":"Nat Chem Biol"},{"key":"R49-20230901","doi-asserted-by":"crossref","first-page":"L1095","DOI":"10.1152\/ajplung.00283.2006","article-title":"Protective effect of orally administered carnosine on bleomycin-induced lung injury","volume":"292","author":"Cuzzocrea","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R50-20230901","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0006-291X(84)91407-4","article-title":"Rat liver histidyl-tRNA synthetase. Purification and inhibition by the myositis-specific anti-Jo-1 autoantibody","volume":"120","author":"Yang","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"R51-20230901","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1021\/bi00392a044","article-title":"Purification of mammalian histidyl-tRNA synthetase and its interaction with myositis-specific anti-Jo-1 antibodies","volume":"26","author":"Fahoum","year":"1987","journal-title":"Biochemistry"},{"key":"R52-20230901","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1172\/JCI116493","article-title":"Reaction of anti-OJ autoantibodies with components of the multienzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase","volume":"91","author":"Targoff","year":"1993","journal-title":"J Clin Invest"},{"key":"R53-20230901","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/nar\/26.2.521","article-title":"Human cytosolic asparaginyl-tRNA synthetase: cDNA sequence, functional expression in Escherichia coli and characterization as human autoantigen","volume":"26","author":"Beaulande","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"R54-20230901","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1096\/fasebj.2.8.2452112","article-title":"Myositis autoantibody reactivity and catalytic function of threonyl-tRNA synthetase","volume":"2","author":"Dang","year":"1988","journal-title":"FASEB J"},{"key":"R55-20230901","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11926-003-0052-2","article-title":"The role of Jo-1 in the immunopathogenesis of polymyositis: current hypotheses","volume":"5","author":"Ascherman","year":"2003","journal-title":"Curr Rheumatol Rep"},{"key":"R56-20230901","doi-asserted-by":"crossref","first-page":"23155","DOI":"10.1074\/jbc.274.33.23155","article-title":"Highly differentiated motifs responsible for two cytokine activities of a split human tRNA synthetase","volume":"274","author":"Wakasugi","year":"1999","journal-title":"J Biol Chem"},{"key":"R57-20230901","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20020186","article-title":"Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells","volume":"196","author":"Howard","year":"2002","journal-title":"J Exp Med"},{"key":"R58-20230901","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1126\/science.1252943","article-title":"Human tRNA synthetase catalytic nulls with diverse functions","volume":"345","author":"Lo","year":"2014","journal-title":"Science"},{"key":"R59-20230901","doi-asserted-by":"crossref","first-page":"7127","DOI":"10.4049\/jimmunol.169.12.7127","article-title":"Critical requirement for professional APCs in eliciting T cell responses to novel fragments of histidyl-tRNA synthetase (Jo-1) in Jo-1 antibody-positive polymyositis","volume":"169","author":"Ascherman","year":"2002","journal-title":"J Immunol"},{"key":"R60-20230901","doi-asserted-by":"crossref","first-page":"19269","DOI":"10.1074\/jbc.C114.571026","article-title":"Secreted histidyl-tRNA synthetase splice variants elaborate major epitopes for autoantibodies in inflammatory myositis","volume":"289","author":"Zhou","year":"2014","journal-title":"J Biol Chem"},{"key":"R61-20230901","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/annrheumdis-2015-208119","article-title":"Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups","volume":"75","author":"Rothwell","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R62-20230901","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/gene.2015.28","article-title":"Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes","volume":"16","author":"Miller","year":"2015","journal-title":"Genes Immun"},{"key":"R63-20230901","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/ar3327","article-title":"Recent advances in the immunogenetics of idiopathic inflammatory myopathy","volume":"13","author":"Chinoy","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R64-20230901","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/BOR.0000000000000328","article-title":"New developments in genetics of myositis","volume":"28","author":"Rothwell","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"R65-20230901","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/art.38270","article-title":"Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis","volume":"66","author":"Aggarwal","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R66-20230901","doi-asserted-by":"crossref","first-page":"9933","DOI":"10.1073\/pnas.87.24.9933","article-title":"The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity","volume":"87","author":"Miller","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R68-20230901","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1096\/fasebj.9.12.7672516","article-title":"Epitope studies indicate that histidyl-tRNA synthetase is a stimulating antigen in idiopathic myositis","volume":"9","author":"Martin","year":"1995","journal-title":"FASEB J"},{"key":"R69-20230901","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1002\/art.22865","article-title":"Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy","volume":"56","author":"Stone","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R70-20230901","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1002\/art.22860","article-title":"A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52\/anti-Ro 60 autoantibodies","volume":"56","author":"Eloranta","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R71-20230901","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/ard.2008.091405","article-title":"Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies","volume":"68","author":"Krystufkov\u00e1","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R72-20230901","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/art.22293","article-title":"Restricted T cell receptor BV gene usage in the lungs and muscles of patients with idiopathic inflammatory myopathies","volume":"56","author":"Englund","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R75-20230901","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.4049\/jimmunol.0803688","article-title":"T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells","volume":"183","author":"Fasth","year":"2009","journal-title":"J Immunol"},{"key":"R76-20230901","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1084\/jem.20041367","article-title":"Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy","volume":"201","author":"Casciola-Rosen","year":"2005","journal-title":"J Exp Med"},{"key":"R77-20230901","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrrheum.2016.200","article-title":"Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis","volume":"13","author":"Catrina","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"R78-20230901","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/ar1862","article-title":"In adult onset myositis, the presence of interstitial lung disease and myositis specific\/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype","volume":"8","author":"Chinoy","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"R79-20230901","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/rheumatology\/kex021","article-title":"A longitudinal cohort study of the antisynthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies","volume":"56","author":"Pinal-Fernandez","year":"2017","journal-title":"Rheumatology"},{"key":"R80-20230901","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.autrev.2012.06.006","article-title":"Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with antitRNA synthetase antibody specificity","volume":"12","author":"Hervier","year":"2012","journal-title":"Autoimmun Rev"},{"key":"R82-20230901","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2796.2011.02459.x","article-title":"KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis","volume":"271","author":"Fathi","year":"2012","journal-title":"J Intern Med"},{"key":"R83-20230901","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/rheumatology\/keq196","article-title":"Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease","volume":"49","author":"Gono","year":"2010","journal-title":"Rheumatology"},{"key":"R84-20230901","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/annrheumdis-2012-202794","article-title":"A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-\u03b1 monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients","volume":"73","author":"Higgs","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R85-20230901","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1056\/NEJMc1412997","article-title":"Remission of recalcitrant dermatomyositis treated with ruxolitinib","volume":"371","author":"Hornung","year":"2014","journal-title":"N Engl J Med"},{"key":"R86-20230901","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet"},{"key":"R87-20230901","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/annrheumdis-2013-203991","article-title":"Efficacy and safety of belimumab in primary Sj\u00f6gren's syndrome: results of the BELISS open-label phase II study","volume":"74","author":"Mariette","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R88-20230901","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3389\/fphys.2017.00508","article-title":"Inhibition of toll-like receptor signaling as a promising therapy for inflammatory diseases: a journey from molecular to nano therapeutics","volume":"8","author":"Gao","year":"2017","journal-title":"Front Physiol"},{"key":"R89-20230901","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.01209-2017","article-title":"Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years","volume":"50","author":"Raghu","year":"2017","journal-title":"Eur Respir J"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201811000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T01:18:07Z","timestamp":1693531087000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201811000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":84,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000555","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}